Stroke Event Rates and the Optimal Antithrombotic Choice of Patients With Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

The risks of stroke or systemic embolism and major bleeding are considered similar between paroxysmal and sustained atrial fibrillation (AF), and warfarin has demonstrated superior efficacy to aspirin, irrespective of the AF type. However, with the advent of novel oral anticoagulants (NOACs) and ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yicong, Zhao, Yuhui, Dang, Ge, Ouyang, Fubing, Chen, Xinran, Zeng, Jinsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291617/
https://www.ncbi.nlm.nih.gov/pubmed/26717376
http://dx.doi.org/10.1097/MD.0000000000002364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291617/
https://www.ncbi.nlm.nih.gov/pubmed/26717376
http://dx.doi.org/10.1097/MD.0000000000002364

Ejemplares similares